Michael Katsnelson
Overview
Explore the profile of Michael Katsnelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan F, Lenneman C, Krone R, Williams G, Outlaw Jr D, Katsnelson M, et al.
Pharmacotherapy
. 2023 Nov;
44(3):214-223.
PMID: 38009283
Background: Vascular endothelial growth factor inhibitors, including tyrosine kinase inhibitors (TKIs) and anti-angiogenics, are first-line therapies for advanced and metastatic hepatocellular carcinoma. Although TKIs have a greater potential for off-target...
2.
Katsnelson M, Koch S, Rundek T
J Atr Fibrillation
. 2017 May;
3(3):279.
PMID: 28496667
Non-valvular atrial fibrillation is a common and from a neurological perspective the most significant cardiac arrhythmia with a growing world-wide incidence. It also carries a significant associated morbidity and mortality,...
3.
Karmakar M, Katsnelson M, Malak H, Greene N, Howell S, Hise A, et al.
J Immunol
. 2015 Jan;
194(4):1763-75.
PMID: 25609842
Although neutrophils are the most abundant cells in acute infection and inflammation, relatively little attention has been paid to their role in inflammasome formation and IL-1β processing. In the present...
4.
Ay H, Arsava E, Andsberg G, Benner T, Brown Jr R, Chapman S, et al.
Stroke
. 2014 Nov;
45(12):3589-96.
PMID: 25378430
Background And Purpose: NINDS (National Institute of Neurological Disorders and Stroke)-SiGN (Stroke Genetics Network) is an international consortium of ischemic stroke studies that aims to generate high-quality phenotype data to...
5.
Koch S, Bustillo A, Campo B, Campo N, Campo-Bustillo I, McClendon M, et al.
J Vasc Interv Neurol
. 2014 Oct;
7(3):18-22.
PMID: 25298854
Background And Purpose: Most data on the prevalence of vertebral artery origin (VAo) disease is derived from hospital-based studies of patients with posterior circulation strokes and TIA. The prevalence of...
6.
McArdle P, Kittner S, Ay H, Brown Jr R, Meschia J, Rundek T, et al.
Neurology
. 2014 Sep;
83(18):1653-60.
PMID: 25261504
Objective: The objective of this study was to assess the level of agreement between stroke subtype classifications made using the Trial of Org 10172 Acute Stroke Treatment (TOAST) and Causative...
7.
Koch S, Bustillo A, Campo B, Campo N, Campo-Bustillo I, McClendon M, et al.
J Vasc Interv Neurol
. 2014 Aug;
7(2):29-33.
PMID: 25132909
Background And Purpose: Vertebral artery origin stenosis prevalence. Most data on the prevalence of vertebral artery origin (VAo) disease is derived from hospital-based studies of patients with posterior circulation strokes...
8.
Gutierrez J, Koch S, Dong C, Casanova T, Modir R, Katsnelson M, et al.
Neurol Sci
. 2013 Oct;
35(4):577-82.
PMID: 24122024
Stroke subtypes have been reported to differ by race and ethnic subgroups and have not been adequately explained. We aim to evaluate if the prevalence of vascular risk factors accounts...
9.
Mayor F, Bilgin-Freiert A, Connolly M, Katsnelson M, Dusick J, Vespa P, et al.
Neurosurgery
. 2013 Jul;
73(5):808-15.
PMID: 23867300
Background: Animal studies suggest that ischemic preconditioning prolongs coagulation times. Objective: Because coagulation changes could hinder the translation of preconditioning into clinical settings where hemorrhage may be an issue, such...
10.